The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Molbio Diagnostics IPO
Molbio Diagnostics
MainboardListed

Molbio Diagnostics IPO

Bidding 10-12 Aug 2026, price band ₹768–807, lot 18 shares.

+21.44%
listing gain
OverviewGMPAllotment

Grey Market Premium Trend

GMP last updated: 17 Aug 2026, 8:53 AM IST

₹116
Final GMP
21.44%
Actual Listing Gain
14.4%
GMP-Implied Gain
₹768 - ₹807
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
16 Aug₹116₹92314.37%
15 Aug₹120₹92714.87%
14 Aug₹125₹93215.49%
13 Aug₹115₹92214.25%
12 Aug₹156₹96319.33%
11 Aug₹154₹96119.08%
10 Aug₹138₹94517.10%
9 Aug₹127₹93415.74%
8 Aug₹132₹93916.36%
7 Aug₹130₹93716.11%
6 Aug₹180₹98722.30%
5 Aug₹220₹1,02727.26%
4 Aug₹170₹97721.07%
3 Aug₹0₹8070.00%

IPO timeline

  1. Issue open date
    10 Aug 2026
  2. Issue close date
    12 Aug 2026
  3. UPI mandate deadline
    12 Aug 2026
  4. Allotment finalization
    13 Aug 2026
  5. Refund initiation
    14 Aug 2026
  6. Share credit
    14 Aug 2026
  7. Listing date
    17 Aug 2026
  8. Mandate end date
    27 Aug 2026
  9. Lock-in end date for anchor investors (50%)
    11 Sep 2026
  10. Lock-in end date for anchor investors (remaining)
    10 Nov 2026

Molbio Diagnostics IPO Allotment Status

Allotment date:13 Aug 2026
Registrar:Kfin Technologies Limited
  1. Open the registrar's allotment page from the link below.
  2. Select Molbio Diagnostics from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Kfin Technologies(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:14 Aug 2026
Shares credited to demat:14 Aug 2026
Listing:17 Aug 2026

IPO Subscription Status

Total subscription:70.27x

Category-wise figures are not available right now.

Quick Stats

Issue Size:940cr
Lot Size:18 shares
Min Investment:₹14,526
P/E Ratio:55.43

Additional Resources

ProspectusRead(Opens in a new tab)

About the Company

Molbio Diagnostics is a point-of-care diagnostics company that develops and manufactures healthcare technologies for diagnosing infectious and non-communicable diseases. The company’s core business revolves around its proprietary ‘Truenat’ platform, a portable, battery-operated polymerase chain reaction (PCR) system designed for use in resource-limited settings. This platform provides rapid and accurate test results within approximately one hour. The company’s primary source of revenue is the sale of its ‘Truenat’ devices and the recurring sale of compatible, disease-specific micro-PCR test kits. Molbio offers a wide range of tests for various infectious diseases, including tuberculosis, COVID-19, Hepatitis B and C, HIV, and HPV. Through its subsidiaries, the company also provides devices related to radiology and digital pathology.

Strengths

  • Proprietary TruNAT platform enables rapid, point-of-care molecular diagnostics.
  • Strong footprint in government and public health procurement programs.
  • Wide disease coverage including TB, COVID-19, HIV, hepatitis and HPV.
  • In-house R&D supported by integrated manufacturing capabilities.
  • Global presence with products deployed across multiple countries.

Risks

  • Heavy dependence on government and international aid agency funding.
  • High revenue concentration from tuberculosis-related test kits.
  • A limited number of large customers contribute a significant share of revenues.
  • Regulatory delays may impact the commercialisation of new diagnostic tests.
  • Demand fluctuations are linked to public health policies and funding cycles.

Molbio Diagnostics IPO – Frequently Asked Questions

  • The price band for the Molbio Diagnostics IPO is set at ₹768 to ₹807 per share.
  • The Molbio Diagnostics IPO opens on August 10, 2026 and closes on August 12, 2026.
  • The tentative listing date for the Molbio Diagnostics IPO is August 17, 2026.
  • The last recorded Grey Market Premium (GMP) for the Molbio Diagnostics IPO before listing was ₹116 (14.37%). GMP is unofficial and is not a guarantee of the listing price.
  • The Molbio Diagnostics IPO listed on August 17, 2026 with a listing gain of 21.44% over its issue price.
  • The Molbio Diagnostics IPO allotment date is August 13, 2026. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Kfin Technologies Limited. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Molbio Diagnostics IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Molbio Diagnostics, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Molbio Diagnostics IPO is 18 shares. Investors must apply for at least one lot (i.e., 18 shares), which costs ₹14,526 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in August 2026